Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients

…, E Dvorackova, J Lastovicka, R Lischke… - The Journal of Heart and …, 2021 - Elsevier
The immunogenicity of the novel mRNA COVID-19 vaccine in immunocompromised lung
transplant recipients is still unknown. We compared the antibody response after the first and …

Predictors of prolonged air leak following pulmonary lobectomy

AJ Stolz, J Schützner, R Lischke… - European journal of …, 2005 - academic.oup.com
Objective: To predict risk factors of a prolonged air leak following pulmonary lobectomy.
Methods: From January 2003 to March 2004, 134 patients (95 male, mean age 66±7.7 years) …

[HTML][HTML] The immune contexture of liposarcoma and its clinical implications

…, L Müller, V Potkrajcic, A Ozaniak, R Lischke… - Cancers, 2022 - mdpi.com
Simple Summary Liposarcomas (LPS) are malignancies arising from adipose tissue. Based
on the histological appearance, five subtypes are distinguished: well-differentiated LPS, …

[HTML][HTML] Transcripts associated with chronic lung allograft dysfunction in transbronchial biopsies of lung transplants

…, GI Snell, GP Westall, J Havlin, R Lischke… - American Journal of …, 2022 - Elsevier
Transplanted lungs suffer worse outcomes than other organ transplants with many developing
chronic lung allograft dysfunction (CLAD), diagnosed by physiologic changes. Histology …

[HTML][HTML] The TRAIL in the treatment of human cancer: an update on clinical trials

…, J Vachtenheim Jr, A Ozaniak, R Lischke… - Frontiers in molecular …, 2021 - frontiersin.org
TRAIL (tumor-necrosis factor related apoptosis-inducing ligand, CD253) and its death
receptors TRAIL-R1 and TRAIL-R2 selectively trigger the apoptotic cell death in tumor cells. For …

Novel biodegradable stents in the treatment of bronchial stenosis after lung transplantation

R Lischke, J Pozniak, D Vondrys… - European journal of …, 2011 - academic.oup.com
Objective: To evaluate the safety and effectiveness of novel biodegradable (BD) stents to treat
bronchial anastomotic stenosis in patients after lung transplantation. Methods: Twenty BD …

[HTML][HTML] Novel insights into the immunotherapy of soft tissue sarcomas: do we need a change of perspective?

A Ozaniak, J Vachtenheim Jr, R Lischke, J Bartunkova… - Biomedicines, 2021 - mdpi.com
Soft tissue sarcomas (STSs) are rare mesenchymal tumors. With more than 80 histological
subtypes of STSs, data regarding novel biomarkers of strong prognostic and therapeutic …

Anastomotic leak and stricture after hand-sewn versus linear-stapled intrathoracic oesophagogastric anastomosis: single-centre analysis of 415 oesophagectomies

…, M Snajdauf, A Stolz, R Lischke - European Journal of …, 2016 - academic.oup.com
OBJECTIVES There seems to be a decreased anastomotic leak rate and a late stricture
formation after linear-stapled (LS) cervical oesophagogastric anastomosis compared with hand-…

Cultivation of circulating tumor cells in esophageal cancer

…, J Szelachowska, R Lischke… - Folia histochemica …, 2014 - journals.viamedica.pl
The presence of circulating tumor cells (CTCs) in patients with metastatic carcinoma is generally
associated with poor clinical outcome. There have been many investigations showing a …

[HTML][HTML] Detection and cultivation of circulating tumor cells in gastric cancer

…, R Gürlich, K Grabowski, K Soter, R Lischke… - Cytotechnology, 2016 - Springer
Circulating tumor cells (CTCs) are important targets for treatment and critical surrogate markers
when evaluating cancer prognosis and therapeutic response. A sensitive methodology …